July 28th marks World Hepatitis Day, a global health awareness day aimed at raising awareness about hepatitis and calling for more actions for liver health. Each year, millions of people die from hepatitis, leaving hundreds of millions more suffering from liver health damage. Additionally, insufficient diagnostics leave over 200 million people suffer from hepatitis without knowing.
Beijing Hotgen Biotech Co., Ltd. is always committed to this call to protect liver health, by offering our comprehensive solutions from (both viral and metabolic) hepatitis detection to early liver cancer screening.
CK18 for Non-Alcoholic Steatohepatitis (NASH) Screening: CK18 are biomarkers to detect non-alcoholic steatohepatitis, facilitating early intervention of the disease.
HBV RNA for Precision Medication Management in Chronic Hepatitis B: Through HBV RNA detection, preciser and more effective medication management for chronic hepatitis B patients is feasible. This unique PCR product will also facilitate doctors to give better prognosis analysis, guaranteeing better long-term health of their patients.
GP73 for Liver Disease Progression Management: GP73 can reflect the progression from hepatitis to fibrosis and cirrhosis, providing timely diagnosis and treatment guidance. According to latest articles on Nature, GP73 plays a pivotal role in liver metabolism and carries more meanings to clinical practices.
Three Liver Cancer Markers / Liver Cancer Trio (AFP, AFP-L3%, DCP): AFP, AFP-L3%, and DCP are well known liver cancer diagnostic biomarkers in clinical field. Applied together simultaneously, they can effectively screen for early liver cancer, offering a chance of diagnosis up to 3 years earlier than the traditional methods and a higher patient survival rate.
Hotgen is consistently dedicated to exploring and expanding the frontier of liver disease diagnostics. Powered by AI and next-generation diagnostic technologies, Hotgen is offering more diagnostic tools, whose precision levels are greater than ever before.
On this World Hepatitis Day, we encourage more interest parties to work together for a healthier future away from liver diseases. And we believe this is achievable with precise and early screening and diagnosis. If any interest to consult more, please feel free to contact us at sales@hotgen.com.cn.
https://www.who.int/campaigns/world-hepatitis-day/2024
English
